GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan says
Summary
According to J.P. Morgan, the rising popularity of GLP-1 medications in China, India, and Brazil could lead to a massive economic opportunity in the coming decade. The financial institution projects that this regional pharmaceutical trend might generate a market value of twenty-two billion dollars by the year 2035.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.